Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Jason B, Dinoso"'
Autor:
Edward V. Loftus, Jie Zhang, Silvio Danese, Jeremy Hsieh, Jason B Dinoso, Gerhard Rogler, Toshifumi Hibi, Chohee Yun, Sally Zhao, Ben Morison, Timothy E Ritter
Publikováno v:
Posters.
Autor:
Angelo Clemenzi-Allen, Jason B Dinoso, Amos Baruch, Oleg Mayba, Alessander O Guimaraes, Carrie M. Rosenberger, Melicent C. Peck, Yi Cao, Kyu Hong, Montserrat Carrasco-Triguero, Henry F. Chambers, Johnny Gutierrez, Stacey A. Maskarinec, Catherine A. Koss, Vance G. Fowler, Felicia Ruffin
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 68, iss 9
BACKGROUND: Staphylococcus aureus is a leading cause of bacteremia, yet there remains a significant knowledge gap in the identification of relevant biomarkers that predict clinical outcomes. Heterogeneity in the host response to invasive S. aureus in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3af5e8aab5d5727c2cb3541a8017912
https://escholarship.org/uc/item/4zm1f9qx
https://escholarship.org/uc/item/4zm1f9qx
Autor:
Henry F. Chambers, Nicholas Lewin-Koh, Jason B Dinoso, Carrie M. Rosenberger, Catherine A. Koss, Joanna K Chang, Alessander O Guimaraes, Melicent C. Peck, Johnny Gutierrez, Janice Kim, Min Xu, Amos Baruch, Angelo Clemenzi-Allen, Donghong Yan, Yi Cao, Aklile Berhanu
Publikováno v:
Open Forum Infectious Diseases. 6
Background Staphylococcus aureus (SA) bacteremia often requires a long treatment duration with antibiotics to prevent relapse due to the ability of SA to establish reservoirs of infection in sites such as heart and bone. These metastatic sites of inf
Autor:
Ola Saad, Jason B Dinoso, Carrie M. Rosenberger, Sanjeev Mariathasan, Chenguang Zhou, Johnny Gutierrez, Kyu Hong, Montserrat Carrasco-Triguero, Neelima Koppada, Amos Baruch, Nina Ljumanovic, Amrita V. Kamath, Sophie M. Lehar
Publikováno v:
mAbs
DSTA4637A, a novel THIOMAB™ antibody antibiotic conjugate (TAC) against Staphylococcus aureus (S. aureus), is currently being investigated as a potential therapy against S. aureus infections. Structurally, TAC is composed of an anti-S. aureus antib
Autor:
Johnny, Gutierrez, Alessander O, Guimaraes, Nicholas, Lewin-Koh, Aklile, Berhanu, Min, Xu, Yi, Cao, Janice, Kim, Donghong, Yan, Joanna K, Chang, Jason B, Dinoso, Catherine A, Koss, Angelo, Clemenzi-Allen, Henry F, Chambers, Melicent C, Peck, Amos, Baruch, Carrie M, Rosenberger
Publikováno v:
Open Forum Infectious Diseases
Background Staphylococcus aureus (SA) bacteremia often requires a long treatment duration with antibiotics to prevent relapse due to the ability of SA to establish reservoirs of infection in sites such as heart and bone. These metastatic sites of inf
Autor:
Joel N. Blankson, Amy E. DeZern, Jason B. Dinoso, Karla Alwood, Christine M. Durand, Julia A. Marsh, Richard F. Ambinder, Adam M. Spivak, Stephanie Gaillard, Karen A. O'Connell
Publikováno v:
Journal of Clinical Virology. 51:195-198
The mechanism of elite control of HIV-1 replication is not fully understood. While immunosuppression due to rituximab based chemotherapy has been associated with increased replication of HBV, CMV, and HIV-1, control of replication-competent HIV-1 was
Autor:
Jason B Dinoso, Alessander O Guimaraes, Amos Baruch, Vance G. Fowler, Catherine A. Koss, Carrie M. Rosenberger, Yi Cao, Angelo Clemenzi-Allen, Stacey A. Maskarinec, Oleg Mayba, Melicent C. Peck, Kyu Hong, Montserrat Carrasco-Triguero, Johnny Gutierrez, Felicia Ruffin, Henry F. Chambers
Publikováno v:
Open Forum Infectious Diseases
Background Staphylococcus aureus is a leading cause of bacteremia, yet there remains a significant knowledge gap in the identification of relevant biomarkers that predict clinical outcomes in patients with S. aureus bacteremia. Heterogeneity in the h
Autor:
Jason B. Dinoso, Hejab Imteyaz, Joel E. Gallant, Susan Langan, Janet D. Siliciano, Joseph B. Margolick, Joel N. Blankson, Tricia L. Nilles, Linda G. Apuzzo, Kendall A. Smith
Publikováno v:
AIDS. 24:932-935
Interleukin (IL)-2 has been studied as a treatment for HIV infection because it stimulates the proliferation of T cells and augments antiviral immune functions [1,2]. Two regimens have been used: intermittent IL-2 (5 days every 8 weeks, usually 4.5
Autor:
Joel N. Blankson, Janice E. Clements, Robert F. Siliciano, Joseph L. Mankowski, S. Alireza Rabi, M. Christine Zink, Lucio Gama, Jason B. Dinoso
Publikováno v:
Journal of Virology. 83:9247-9257
The treatment of human immunodeficiency virus type 1 (HIV-1) infection with highly active antiretroviral therapy (HAART), a combination of three or more antiretroviral drugs, suppresses viremia below the clinical limit of detection (50 HIV-1 RNA copi
Publikováno v:
Biochemical and Biophysical Research Communications. 317:648-653
The Saccharomyces cerevisiae gene ABC1 was originally isolated as a multicopy suppressor of a yeast strain harboring a mutation in a cytochrome b translational activator (cbs2-223). Based on this identification, Abc1p was postulated to activate the b